HKAPI submits an opinion paper, on behalf of its 33 member companies engaging in the research and development of novel pharmaceuticals, and providing 70% of treatment drugs in Hong Kong.
The Hong Kong Association of The Pharmaceutical Industry (HKAPI) held its Annual General Meeting on 2 April 2020 and delighted to announce the formation of the New Board (2020 – 2022).
With the support from member companies in sourcing protective equipment all over the world, 17,000 surgical face masks have were delivered to Patient Groups to support patients in the current outbreak of Coronavirus disease.
HKAPI statement on Novel Coronavirus The Hong Kong Association of the pharmaceutical Industry (HKAPI) representing 34 R&D multinational pharmaceutical companies in Hong Kong, providing 70% of prescription medicine in Hong […]
On December 18, 2019, around 70 members from the regulatory affairs and pharmacovigilance department attended the New Product submission and Best Practice Workshop held at HKU.
On 3 December 2019, our “HKAPI Medical Representative Training Programme” students have finally come to their graduation. Over 100 guests and graduating students attended the graduation ceremony held at Hong Kong Arts Centre.
On December 2, 2019, about 70 members coming from areas such as senior management, marketing and medical affairs attended the “Market Access Workshop” in Harbour Plaza, North Point.
On November 19, 2019, about 80 members, including senior management, marketers and medical staff, turned up at the "Code of Practice Train-the-trainers Workshop" in Hong Kong Arts Centre, Wan Chai.